Skip to Main Content

Paper Details

RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
PLoS Pathog
20
2019
Author NameAffiliation
Laura Martin-SanchoMax Planck Institute for Infection Biology
Thomas F MeyerMax Planck Institute for Infection Biology
Thomas F MeyerSteinbeis Innovation Center for Systems Biomedicine
Alexander KarlasMax Planck Institute for Infection Biology
Alexander KarlasSteinbeis Innovation Center for Systems Biomedicine
  • 1 - 5

Datasets

Release 1.2